WHO ICTRP trial
Colchicine prophylaxis in gout patients commencing urate lowering therapy
ACTRN12618001179224 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12618001179224 |
|---|---|
| Public title | Colchicine prophylaxis in gout patients commencing urate lowering therapy |
| Scientific title | Safety and efficacy study of colchicine prophylaxis in gout patients commencing urate lowering therapy |
| Primary sponsor | University of Otago |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | New Zealand;New Zealand |
| Conditions | Gout; Gout;Musculoskeletal - Other muscular and skeletal disorders;Inflammatory and Immune System - Other inflammatory or immune system disorders |
| Interventions | The intervention is colchicine 0.5mg as an oral capsule daily for six months. Adherence will be monitored by a drug tablet return at three month and six month study visits. Colchicine and allopurinol will be commenced together at the… |
| Registration date | Jul 17, 2018 |
| Target size | 200 |
| Secondary IDs | Nil known |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: